NIFTY23,930.301.00%
SENSEX76,804.011.11%
BANKNIFTY55,990.900.56%
NIFTY IT28,845.204.25%
PHARMA22,630.051.55%
AUTO25,737.800.35%
FMCG50,721.000.82%
METAL12,670.350.91%
REALTY779.851.12%
ENERGY39,704.500.73%
NIFTY23,930.301.00%
SENSEX76,804.011.11%
BANKNIFTY55,990.900.56%
NIFTY IT28,845.204.25%
PHARMA22,630.051.55%
AUTO25,737.800.35%
FMCG50,721.000.82%
METAL12,670.350.91%
REALTY779.851.12%
ENERGY39,704.500.73%

Infosys Posts Stable Quarter, But FY27 Outlook Remains a Concern

Infosys, a leading global consulting and technology services company, has delivered a stable quarter with broadly positive full-year performance. However, the company's guidance for the fiscal year 2027 (FY27) has weighed on the overall outlook.

Record Deal Wins and Revenue Visibility The company's record USD-15 billion deal wins and 24% year-over-year (YoY) total contract value (TCV) growth are genuine positives that underpin revenue visibility for FY27. These achievements demonstrate the company's ability to secure large-scale contracts and drive revenue growth.

Challenges Ahead Despite the positive deal wins, Infosys faces several challenges that may cap near-term revenue growth. The company's flat volume trends, limited clarity on AI-related deflation, and a 75-100 bps impact from a European manufacturing client are expected to exert pressure on revenue growth. Additionally, onsite mix pressures are likely to limit revenue growth to around 3.5% unless macro conditions improve.

Read also: PropShare Celestia Makes Debut on Stock Market at 4.8% Discount

Guidance and Outlook While narrowing down the guidance range signals confidence, the FY27 midpoint of 2.5% constant currency (CC) growth suggests only a modest improvement over FY26's underlying growth. Factoring in the muted outlook, we forecast Revenue/EBIT/PAT to grow at a compound annual growth rate (CAGR) of 9.3%/9.9%/8.0% over FY26-FY29E.

Fiscal YearRevenue CAGREBIT CAGRPAT CAGR
FY26-FY27E9.3%9.9%8.0%
FY27E-FY28E8.5%9.1%7.5%
FY28E-FY29E8.0%8.5%7.0%

Recommendation Based on our analysis, we reiterate our BUY rating for Infosys, revising our target price to INR 1,500 (from INR 1,650) based on FY28E EPS of INR 83.

Investor Takeaway

Investors should consider revising their target price for Infosys to INR 1,500 based on the latest report.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.